Loading…
Lobbying Spend
—
Filings
10
Firms Hired
1
Active Period
2024–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Event Contract Enforcement Act
2026 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Client expense: — · Firm income: —
Matched citations: HR7840
Event Contract Enforcement Act
2026 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Client expense: — · Firm income: —
Matched citations: HR7840
Event Contract Enforcement Act
2026 · second_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Client expense: — · Firm income: $10,000
Matched citations: HR7840
Event Contract Enforcement Act
2026 · second_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Client expense: — · Firm income: $10,000
Matched citations: HR7840
Event Contract Enforcement Act
2026 · first_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Client expense: — · Firm income: $20,000
Matched citations: HR7840
Event Contract Enforcement Act
2026 · first_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Client expense: — · Firm income: $20,000
Matched citations: HR7840
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $10,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $10,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $10,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $10,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $30,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $30,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $30,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $30,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · second_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · second_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · second_quarter · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 4121
Source: Senate LDA